Latest Breaking News On - Swiss innovation agency - Page 6 : comparemela.com

Gain Therapeutics Awarded CHF 2 5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson s Disease

BETHESDA, Md., May 03, 2023 Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced that Innosuisse, the. | May 3, 2023

Matthias alderSwiss innovation agencyCompany swiss acceleratorGain therapeutics incMichaelj fox foundation for parkinson researchCompany annual report on formSilverstein foundation for parkinsonExchange commissionSwiss acceleratorStructurally targeted allosteric regulatorsChief executive officerManolo bellottoChief strategy officerGeneral managerGain therapeuticsSilverstein foundation

Gain Therapeutics (GANX) Awarded CHF 2 5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson s Disease

Gain Therapeutics (GANX) Awarded CHF 2 5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matthias alderSwiss innovation agencyGain therapeutics incCompany swiss acceleratorSwiss acceleratorStructurally targeted allosteric regulatorsChief executive officerManolo bellottoChief strategy officerGeneral managerGain therapeutics

Gain Therapeutics Awarded CHF 2 5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson s Disease

Gain Therapeutics Awarded CHF 2 5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matthias alderCompany annual report on formMichaelj fox foundation for parkinson researchCompany swiss acceleratorExchange commissionGain therapeutics incSilverstein foundation for parkinsonSwiss innovation agencySwiss acceleratorStructurally targeted allosteric regulatorsChief executive officerManolo bellottoChief strategy officerGeneral managerGain therapeuticsSilverstein foundation

Transitional measure for Horizon Europe: Innosuisse supports 53 projects within the framework of the Swiss Accelerator

Current information from the Federal Administration. All press releases from the Federal Administration, the departments and offices.

Eliane kerstenLukas krienbuehlSwiss innovation agencyInnovation council of innosuisseSwiss innovation promotion agencyAccelerator of the european innovation councilSwiss innovation promotionSwiss acceleratorEuropean innovationInnovation councilPress release

Swiss innovation body supports 53 projects

The Swiss Innovation Agency (Innosuisse) has approved 53 innovation projects of SMEs and start-ups with grants totalling CHF112 million.

European innovation councilSwiss innovation agency innosuisseSwiss innovation agencySwiss acceleratorLatest newsMicro scienceMarine scienceWeather scienceEnvironmental politicsComputing and information technologyMaterial scienceEnergy and resourceSci amp tech